vs

Side-by-side financial comparison of CATO CORP (CATO) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

CATO CORP is the larger business by last-quarter revenue ($155.4M vs $121.8M, roughly 1.3× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -3.3%, a 7.6% gap on every dollar of revenue. On growth, CATO CORP posted the faster year-over-year revenue change (6.3% vs -1.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-12.9M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -5.7%).

The Cato Corporation is an American retailer of women's fashions and accessories. The company is headquartered in Charlotte, North Carolina. As of January 2016, the company operated 1,372 stores under the names Cato, Cato Plus, It's Fashion, It's Fashion Metro and Versona.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

CATO vs CLB — Head-to-Head

Bigger by revenue
CATO
CATO
1.3× larger
CATO
$155.4M
$121.8M
CLB
Growing faster (revenue YoY)
CATO
CATO
+7.8% gap
CATO
6.3%
-1.4%
CLB
Higher net margin
CLB
CLB
7.6% more per $
CLB
4.2%
-3.3%
CATO
More free cash flow
CLB
CLB
$13.4M more FCF
CLB
$517.0K
$-12.9M
CATO
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-5.7%
CATO

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CATO
CATO
CLB
CLB
Revenue
$155.4M
$121.8M
Net Profit
$-5.2M
$5.1M
Gross Margin
32.7%
Operating Margin
-5.3%
1.5%
Net Margin
-3.3%
4.2%
Revenue YoY
6.3%
-1.4%
Net Profit YoY
65.6%
EPS (diluted)
$-0.28
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CATO
CATO
CLB
CLB
Q1 26
$121.8M
Q4 25
$155.4M
$138.3M
Q3 25
$176.5M
$134.5M
Q2 25
$170.2M
$130.2M
Q1 25
$157.9M
$123.6M
Q4 24
$146.2M
$129.2M
Q3 24
$168.6M
$134.4M
Q2 24
$177.1M
$130.6M
Net Profit
CATO
CATO
CLB
CLB
Q1 26
$5.1M
Q4 25
$-5.2M
$4.9M
Q3 25
$6.8M
$14.2M
Q2 25
$3.3M
$10.6M
Q1 25
$-14.1M
$-154.0K
Q4 24
$-15.1M
$7.4M
Q3 24
$95.0K
$11.7M
Q2 24
$11.0M
$9.0M
Gross Margin
CATO
CATO
CLB
CLB
Q1 26
Q4 25
32.7%
20.8%
Q3 25
36.8%
22.0%
Q2 25
35.8%
20.3%
Q1 25
29.2%
19.5%
Q4 24
29.6%
17.8%
Q3 24
35.3%
20.5%
Q2 24
36.5%
21.2%
Operating Margin
CATO
CATO
CLB
CLB
Q1 26
1.5%
Q4 25
-5.3%
11.5%
Q3 25
3.1%
15.6%
Q2 25
2.0%
11.7%
Q1 25
-15.2%
3.6%
Q4 24
-11.6%
11.0%
Q3 24
-0.4%
14.7%
Q2 24
3.5%
12.3%
Net Margin
CATO
CATO
CLB
CLB
Q1 26
4.2%
Q4 25
-3.3%
3.6%
Q3 25
3.9%
10.6%
Q2 25
1.9%
8.2%
Q1 25
-8.9%
-0.1%
Q4 24
-10.3%
5.7%
Q3 24
0.1%
8.7%
Q2 24
6.2%
6.9%
EPS (diluted)
CATO
CATO
CLB
CLB
Q1 26
$0.11
Q4 25
$-0.28
$0.11
Q3 25
$0.35
$0.30
Q2 25
$0.17
$0.22
Q1 25
$-0.73
$0.00
Q4 24
$-0.79
$0.15
Q3 24
$0.01
$0.25
Q2 24
$0.54
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CATO
CATO
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$79.0M
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$167.6M
$275.1M
Total Assets
$450.2M
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CATO
CATO
CLB
CLB
Q1 26
$22.8M
Q4 25
$79.0M
$22.7M
Q3 25
$90.8M
$25.6M
Q2 25
$80.0M
$31.2M
Q1 25
$77.7M
$22.1M
Q4 24
$86.2M
$19.2M
Q3 24
$104.7M
$21.5M
Q2 24
$105.4M
$17.7M
Total Debt
CATO
CATO
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CATO
CATO
CLB
CLB
Q1 26
$275.1M
Q4 25
$167.6M
$266.0M
Q3 25
$172.2M
$271.3M
Q2 25
$164.9M
$261.3M
Q1 25
$162.3M
$253.4M
Q4 24
$177.1M
$246.6M
Q3 24
$195.1M
$250.7M
Q2 24
$196.9M
$240.3M
Total Assets
CATO
CATO
CLB
CLB
Q1 26
$587.7M
Q4 25
$450.2M
$584.0M
Q3 25
$436.9M
$591.4M
Q2 25
$440.8M
$602.1M
Q1 25
$452.4M
$591.5M
Q4 24
$424.4M
$585.1M
Q3 24
$455.6M
$600.5M
Q2 24
$477.1M
$597.8M
Debt / Equity
CATO
CATO
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CATO
CATO
CLB
CLB
Operating Cash FlowLast quarter
$-12.4M
$4.0M
Free Cash FlowOCF − Capex
$-12.9M
$517.0K
FCF MarginFCF / Revenue
-8.3%
0.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$-7.5M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CATO
CATO
CLB
CLB
Q1 26
$4.0M
Q4 25
$-12.4M
$7.9M
Q3 25
$11.8M
$8.5M
Q2 25
$3.9M
$13.9M
Q1 25
$-6.5M
$6.7M
Q4 24
$-22.1M
$20.6M
Q3 24
$3.1M
$13.1M
Q2 24
$5.7M
$17.1M
Free Cash Flow
CATO
CATO
CLB
CLB
Q1 26
$517.0K
Q4 25
$-12.9M
$5.0M
Q3 25
$10.4M
$6.5M
Q2 25
$2.8M
$10.4M
Q1 25
$-7.8M
$3.9M
Q4 24
$-23.8M
$17.4M
Q3 24
$1.6M
$10.4M
Q2 24
$2.4M
$14.3M
FCF Margin
CATO
CATO
CLB
CLB
Q1 26
0.4%
Q4 25
-8.3%
3.6%
Q3 25
5.9%
4.8%
Q2 25
1.7%
8.0%
Q1 25
-5.0%
3.1%
Q4 24
-16.3%
13.4%
Q3 24
0.9%
7.7%
Q2 24
1.4%
10.9%
Capex Intensity
CATO
CATO
CLB
CLB
Q1 26
Q4 25
0.3%
2.1%
Q3 25
0.8%
1.5%
Q2 25
0.6%
2.7%
Q1 25
0.9%
2.3%
Q4 24
1.2%
2.5%
Q3 24
0.9%
2.0%
Q2 24
1.8%
2.2%
Cash Conversion
CATO
CATO
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
1.72×
0.60×
Q2 25
1.17×
1.31×
Q1 25
Q4 24
2.78×
Q3 24
32.95×
1.12×
Q2 24
0.52×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CATO
CATO

Retail Segment$154.7M100%
Credit Card$5.3M3%

CLB
CLB

Segment breakdown not available.

Related Comparisons